Insider · CIK 0001833910
Gillian Cannon
Files at CORT (CORCEPT THERAPEUTICS INC), XENE (Xenon Pharmaceuticals Inc.). First filing Jun 8, 2026, latest Jun 8, 2026.
In brief
Gillian Cannon files SEC Form 4 as director at XENE (Xenon Pharmaceuticals Inc.), and also at CORT (CORCEPT THERAPEUTICS INC). Since Jun 8, 2026, Gillian Cannon has reported 0 open-market buys worth $0 and 1 open-market sell worth $63k, the latest filed on Jun 8, 2026.
A track record needs three past buys with six months of prices behind them; Gillian Cannon has 0, so none is measured yet.
The newest scored trade: sold $63k of XENE on Jun 5, 2026, filed Jun 8, 2026, scored 21 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $63k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XENE: Xenon Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | Xenon Pharmaceuticals Inc. | $63k 1,190 shares | -45% | +71% from low-18% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 5, 2026 | XENE XENON PHARMACEUTICALS INC. | 1,190 0.00% of outstanding | $63k | Jun 5, 2026 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | XENE Xenon Pharmaceuticals Inc. | SOpen-market sale Common Shares10b5-1 | -1,190 | $53.14 | $63k | 1,455 | Jun 8, 2026 |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Common Shares | +2,645 | - | - | 2,645 | Jun 3, 2026 |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Restricted Share Unitsderivative | -2,645 | $0.00 | $0 | 0 | Jun 3, 2026 |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Share Option (Right to Buy)derivative | +10,507 | $0.00 | $0 | 10,507 | Jun 3, 2026 |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Restricted Share Unitsderivative | +1,593 | $0.00 | $0 | 1,593 | Jun 3, 2026 |
| Sep 10, 2025 | CORT CORCEPT THERAPEUTICS INC | GGift Common Stock | -7,393 | $0.00 | $0 | 0 | Sep 11, 2025 |
| Sep 4, 2025 | CORT CORCEPT THERAPEUTICS INC | MOption exercise Common Stock | +11,000 | $22.99 | $253k | 11,000 | Sep 8, 2025 |
| Sep 4, 2025 | CORT CORCEPT THERAPEUTICS INC | FTax withholding Common Stock | -3,607 | $70.13 | $253k | 7,393 | Sep 8, 2025 |
| Sep 4, 2025 | CORT CORCEPT THERAPEUTICS INC | MOption exercise Stock option (right to buy)derivative | -11,000 | $0.00 | $0 | 49,000 | Sep 8, 2025 |
| Jun 10, 2025 | CORT CORCEPT THERAPEUTICS INC | AGrant or award Stock option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 12, 2025 |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Share Option (Right to Buy)derivative | +17,012 | $0.00 | $0 | 17,012 | Jun 6, 2025 |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Restricted Share Unitsderivative | +2,645 | $0.00 | $0 | 2,645 | Jun 6, 2025 |
| Jun 5, 2024 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,542 | $0.00 | $0 | 15,542 | Jun 5, 2024 |
| May 17, 2024 | CORT CORCEPT THERAPEUTICS INC | AGrant or award Stock option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | May 21, 2024 |
Questions about Gillian Cannon
Answered from the filings on this page, as of the latest one.
Is Gillian Cannon buying or selling?
In the last 12 months Gillian Cannon reported 0 open-market buys worth $0 and 1 open-market sell worth $63k on SEC Form 4; the latest was sold $63k of XENE on Jun 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Gillian Cannon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gillian Cannon has 0.
Where does Gillian Cannon file Form 4?
Gillian Cannon has filed Form 4 at XENE (Xenon Pharmaceuticals Inc.); CORT (CORCEPT THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.